Company news
Sophia Genetics Sa (NASDAQ:SOPH) news
Sophia Genetics Sa news releases on 6ix. Latest, Aug 4, 2026: SOPHiA GENETICS Reports Second Quarter 2026 Results
Press releases & updates
SOPHiA GENETICS Reports Second Quarter 2026 Results
August 4, 2026
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
August 4, 2026
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026
July 21, 2026
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
June 22, 2026
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
June 19, 2026
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
June 16, 2026
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
June 16, 2026
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
June 10, 2026
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center
June 3, 2026
SOPHiA GENETICS : and ARC Regulatory Collaborate to Support EU Clinical Trial Assay Development
June 1, 2026
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
May 13, 2026
SOPHiA GENETICS Reports First Quarter 2026 Results
May 5, 2026
SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026
April 21, 2026
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
April 16, 2026
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results
March 2, 2026
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
February 24, 2026
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026
February 17, 2026
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems
February 10, 2026
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
January 12, 2026
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology
January 7, 2026
SOPHiA GENETICS : Tyrolpath Adopts MSK-IMPACT®-Flex powered with SOPHiA DDM™ to Expand Precision Oncology in Austria
December 4, 2025
SOPHiA GENETICS : Seguros SURA Colombia Adopts MSK-ACCESS® powered by SOPHiA DDM™
November 19, 2025
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
November 11, 2025
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
November 11, 2025
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025
November 10, 2025
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
November 4, 2025
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
October 21, 2025
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
October 16, 2025
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
October 15, 2025
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
September 22, 2025
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
September 22, 2025
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
September 22, 2025
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology
September 5, 2025
SOPHiA GENETICS Reports Second Quarter 2025 Results
August 5, 2025
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
August 5, 2025
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025
July 22, 2025
SOPHiA GENETICS Reports First Quarter 2025 Results
May 6, 2025
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
April 28, 2025
SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025
April 22, 2025
Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities
April 7, 2025
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
March 18, 2025
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results
March 4, 2025
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
February 24, 2025
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025
February 18, 2025
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
January 27, 2025
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
November 20, 2024
SOPHiA GENETICS Reports Third Quarter 2024 Results
November 4, 2024
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer
November 4, 2024
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024
October 21, 2024
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024
September 13, 2024